Full Press Release Details
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 11, 2021 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences:
Jefferies London Health Conference – Participating in a virtual fireside chat on Thursday, November 18, 2021, at 8:00 a.m. GMT.
Evercore ISI 4th Annual HealthconX Conference – Participating in a virtual fireside chat on Thursday, December 2, 2021, at 3:55 p.m. ET.
Webcasts of the fireside chats will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the events.
About ORIC Pharmaceuticals, Inc.
Dominic Piscitelli, Chief Financial Officer